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Abstract— Brain-machine interfaces (BMI) have largely 
been demonstrated in laboratory conditions involving, mainly, 
healthy users. We have recently carried out a series of studies 
with a substantial number of motor-disabled end-users 
operating different brain-controlled devices in ecological 
conditions and without the assistance of BMI experts. 
I. INTRODUCTION 
In the European integrated project TOBI (Tools for 
Brain-Computer Interaction), we have started to combine 
brain-machine interfaces (BMI) and assistive technologies [1] 
in order to develop a variety of practical devices for 
motor-disabled people. These brain-controlled prototypes 
range from text entry systems [2], to telepresence robots [3] 
and to rehabilitation devices [4]. In total, these prototypes 
have been tested by nineteen end-users and patients suffering 
from mild to severe levels of motor impairment. Importantly, 
tests have been mostly carried out by non-BMI experts 
outside our lab. In particular, experiments took place at the 
patients’ clinic (in the case of rehabilitation) and end-users’ 
home or an assistive technology support center [5]. 
II. METHODS 
All three BMI devices are based on the voluntary 
modulation of electrical rhythmic brain activity measured 
with electroencephalogram (EEG). The BMI differentiates 
between two motor imagery tasks, plus intentional 
non-control. This is achieved through the use of a 
probabilistic classifier with evidence accumulation [6, 7]. 
Our BMI approach incorporates some additional principles 
—in particular, shared control— so as to increase reliability, 
reduce workload, and facilitate split attention. 
For the text entry and telepresence robot, end-users need 
first to undertake a period of training in order to learn to 
modulate some control features of their EEG (frequencies at 
certain locations). Participants had to achieve a stable and 
high level of BMI performance (! 70%) after no more than 
5–7 two-hour sessions, which were carried out once or twice 
per week. Only then, were they allowed to progress to the 
evaluation of the brain-controlled prototype devices. The 
subjects selected to take part in these studies were affected by 
different levels of myopathy, spinal cord injury, tetraglegia, 
spino-cerebellar ataxia, or multiple sclerosis. 
In the case of the rehabilitation system, stroke patients did 
not need to train to achieve a specific level of BCI 
performance before progressing to the therapy. Instead we 
directly exploited any discriminant EEG feature functionally 
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related to execution (or the attempted execution) of the target 
motor task to rehabilitate —extension of the affected hand in 
our case. Four chronic stroke patients performed a total of 10 
rehabilitation sessions, two sessions per week.
III. RESULTS AND CONCLUSIONS 
Despite the short and non-intense training period, around 
50% of the end-users mastered their BMI well enough to 
progress to the brain-controlled device tests (telepresence 
robot and text entry system). All succeeded in operating the 
devices, and many tried both. In total, 6 end-users tested the 
text-entry system and 9 end-users tested the telepresence 
robot. This is not a trivial achievement, as good BMI control 
does not necessarily transfer into proper operation of the 
device, which requires split-attention between the BMI task 
and the application itself. In the case of the chronic stroke 
patients, all four carried out their rehabilitation protocol 
satisfactorily and achieved significant improvements in their 
clinical scores (Fugl-Meyer). 
Altogether, these results indicate that BMIs are mature 
enough to start leaving the laboratory and entering daily 
environments of end-users (homes and assistive technology 
support centers) and patients (clinics). Our future work will 
focus on extending the clinical evaluation with more subjects 
and on improving the underlying principles of our BMI. 
ACKNOWLEDGMENT 
We warmly thank all patients and end-users, as well as all 
our partners: Clinique Romande de Réadaptation-Suvacare, 
Switzerland; Klinik für Paraplegiologie, Universitätsklinikum 
Heidelberg, Germany; Associazione Italiana per l’Assistenza 
agli Spastici provincia di Bologna, Italy. 
REFERENCES 
[1] J. d. R. Millán, R. Rupp, G. Müller-Putz, et al., “Combining 
brain-computer interfaces and assistive technologies: State-of-the-art 
and challenges,” Front. Neurosci., vol. 4, 161, 2010. 
[2] S. Perdikis, A. Ramsey, R. Leeb, J. Williamson, A. Al-Khodairy, R. 
Murray-Smith, and J. d. R. Millán, “Clinical evaluation of a 
hybrid-BCI text-entry system,” in Proc. TOBI Workshop III, 2012. 
[3] L. Tonin, T. Carlson, R. Leeb, and J. d. R. Millán, “Brain-controlled 
telepresence robot by motor-disabled people,” in Proc. Annual Intl. 
Conf. IEEE Eng. Med. Biol. Soc., 2011. 
[4] A. Biasiucci, R. Leeb, A. Al-Khodairy, V. Buhlmann, and J. d. R. 
Millán, “Brain controlled functional electrical stimulation for motor 
recovery after stroke,” in Proc. TOBI Workshop IV, 2013. 
[5] R. Leeb, S. Perdikis, L. Tonin, A. Biasiucci, M. Tavella, A. Molina, 
A. Al-Khodairy, T. Carlson, and J. d. R. Millán, “Transferring 
brain-computer interface skills: From simple BCI training to 
successful application control,” Artif. Intell. Med., in revision, 2013. 
[6] J. d. R. Millán, P. W. Ferrez, F. Galán, E. Lew, and R. Chavarriaga, 
“Non-invasive brain-machine interaction,” Int. J. Pattern Recognition 
Art. Intell., vol. 22, pp. 959–972, 2008. 
[7] S. Perdikis, H. Bayati, R. Leeb, and J. d. R. Millán, “Evidence 
accumulation in asynchronous BCI,” Int. J. Bioelectromagnetism, vol. 
13, pp. 131–132, 2011. 
Brain-Machine Interfaces: Progress in Large Clinical Validation 
José del R. Millán, Tom Carlson, Luca Tonin, Serafeim Perdikis, Andrea Biasiucci and Robert Leeb 
